This review discusses anticoagulants' impact on patient outcomes in intracranial hemorrhage, suggesting improved reversal strategies for better management.
Patients who present with intracranial hemorrhage (ICH) require prompt diagnosis and emergent treatment. Anticoagulants are an independent predictor of poor outcomes in patients with acute ICH patients. Therefore, discontinuation of the offending medication and anticoagulation reversal, along with aggressive blood pressure management, is of utmost importance. This article provides a review of anticoagulation-associated ICH, including common anticoagulant medications and reversal agents. Evidence-based guidelines are applied to explain the current medical management paradigm as well as emerging therapies to improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Ranasinghe et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: